Okay, thank you.
I would like to move on to the intellectual property issues. We talked about drug patents. That's been a matter of increasing concern because of the cost to provincial health care plans but also the geographical indications.
I've been to public meetings in Nova Scotia and southern Ontario, and that's something that particularly the agricultural sector is raising more and more: the costs to businesses to have the geographical indications brought to bear and what that means to small businesses in some of our rural areas.
Has the department done any sort of estimate around the cost of intellectual property to Canadian health care plans and the cost to businesses of moving to geographical indications?